Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study.
Joustra VW. et al, (2025), Lancet Gastroenterol Hepatol
DECREASED CD8A AND CD8B EXPRESSING BLOOD T CELL POPULATIONS MAY PREDICT ADALIMUMAB AND INFLIXIMAB RESPONSE FAILURE IN CROHN'S DISEASE PATIENTS
Mol F. et al, (2025), GASTROENTEROLOGY, 169
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis.
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
HIGHER PREDICTIVE POWER OF EPIGENETIC SIGNATURES FOR RESPONSE TO VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF NAIVE PATIENTS WITH ACTIVE CROHN'
van Zon S. et al, (2024), GASTROENTEROLOGY, 166, S1413 - S1413
SPATIALLY RESOLVED INSIGHTS INTO FISTULATING CROHN'S DISEASE PATHOGENESIS: UNVEILING MOLECULAR HETEROGENEITY
McGregor C. et al, (2024), GASTROENTEROLOGY, 166, S47 - S47
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
Wong S-Y. et al, (2023), Inflamm Bowel Dis, 29, 1693 - 1705
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Adams A. et al, (2023), Gut, 72, 433 - 442
EPIGENOME-WIDE PERIPHERAL BLOOD DNA METHYLATION PROFILES ACCURATELY PREDICT ENDOSCOPIC- AND CLINICAL RESPONSE AND REMAIN HIGHLY STABLE DURING INDUCTION AND MAINTENANCE TREATMENT WITH ADALIMUMAB, VEDOLIZUMAB AND USTEKINUMAB IN CROHN'S DISEASE PATIENTS
Joustra V. et al, (2023), GASTROENTEROLOGY, 164, S101 - S101
Pathogenesis of Fistulating Crohn's Disease: A Review.
McGregor CGC. et al, (2023), Cell Mol Gastroenterol Hepatol, 15, 1 - 11
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400
REAL WORLD EFFECTIVENESS OF USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE: A REGIONAL EXPERIENCE
Mcgregor C. et al, (2021), GUT, 70, A108 - A108
Pain, well-being, body image and cosmesis: a comparison of single-port and four-port laparoscopic cholecystectomy.
Sodergren MH. et al, (2014), Minim Invasive Ther Allied Technol, 23, 223 - 229
A randomised comparative study evaluating learning curves of novices in a basic single-incision laparoscopic surgery task.
Sodergren M. et al, (2013), J Gastrointest Surg, 17, 569 - 575
Evaluating systemic stress response in single port vs. multi-port laparoscopic cholecystectomy.
McGregor CGC. et al, (2011), J Gastrointest Surg, 15, 614 - 622